All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Pharmamar SA, of Madrid, Spain, said it inked a licensing deal with Eczacıbaşı Group, of Istanbul, to commercialize marine-derived cancer drug Aplidin (plitidepsin) in Turkey.
